Pages that link to "Q33767211"
Jump to navigation
Jump to search
The following pages link to Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials (Q33767211):
Displaying 50 items.
- Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials (Q21132402) (← links)
- Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview (Q22306433) (← links)
- Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties (Q24307391) (← links)
- Aspirin, cyclooxygenase inhibition and colorectal cancer (Q24598813) (← links)
- Genome-environment interactions that modulate aging: powerful targets for drug discovery (Q24615803) (← links)
- The ancient drug salicylate directly activates AMP-activated protein kinase (Q24630758) (← links)
- Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial (Q24633239) (← links)
- Diagnostics and Epidemiology of Colorectal Cancer (Q26738813) (← links)
- The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer (Q26738873) (← links)
- A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers (Q26739665) (← links)
- Targeting inflammation in pancreatic cancer: Clinical translation (Q26751686) (← links)
- Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill (Q26753102) (← links)
- Chemoprevention studies within lung cancer screening programmes (Q26774588) (← links)
- MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer (Q26777313) (← links)
- Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer (Q26782494) (← links)
- Cancer risk assessment tools in primary care: a systematic review of randomized controlled trials (Q26786902) (← links)
- Molecular cancer prevention: Current status and future directions (Q26797207) (← links)
- Evolutionary determinants of cancer (Q26801710) (← links)
- The failure of cancer chemoprevention (Q26822900) (← links)
- The gastrointestinal tumor microenvironment (Q26827391) (← links)
- Can Aspirin and Cancer Prevention be Ageless Companions? (Q26827455) (← links)
- Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention (Q26849435) (← links)
- Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality (Q26849459) (← links)
- Evolving management of symptomatic chronic subdural hematoma: experience of a single institution and review of the literature (Q26862513) (← links)
- A systematic review of aspirin in primary prevention: is it time for a new approach? (Q26864015) (← links)
- Applying what we know to accelerate cancer prevention (Q26864696) (← links)
- Lung cancer chemoprevention: current status and future prospects (Q26995495) (← links)
- Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise (Q26996419) (← links)
- Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options (Q26996612) (← links)
- Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets (Q26998976) (← links)
- Genetically engineered mouse models of pancreatic adenocarcinoma (Q27002973) (← links)
- COX-2 and PGE2-dependent immunomodulation in breast cancer (Q27003937) (← links)
- Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence (Q27010314) (← links)
- Tumor stroma as targets for cancer therapy (Q27015980) (← links)
- The role of the T cell in age-related inflammation (Q27026492) (← links)
- COX-2 Inhibitors and Gastric Cancer (Q27692701) (← links)
- Bidirectional interconversion of stem and non-stem cancer cell populations: A reassessment of theoretical models for tumor heterogeneity (Q28066409) (← links)
- Repurposing of approved cardiovascular drugs (Q28074453) (← links)
- Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches (Q28080472) (← links)
- The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism (Q28087427) (← links)
- The hallmarks of aging (Q28131641) (← links)
- Rapalogs and mTOR inhibitors as anti-aging therapeutics (Q28286510) (← links)
- Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention (Q28388931) (← links)
- Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? (Q28391921) (← links)
- Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies (Q28395597) (← links)
- Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma (Q28397153) (← links)
- Life history trade-offs in cancer evolution (Q28657962) (← links)
- EMT and dissemination precede pancreatic tumor formation (Q29615854) (← links)
- Inflammation meets cancer, with NF-κB as the matchmaker (Q29620242) (← links)
- Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention. (Q30241072) (← links)